We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$524M
Cap. Flow %
386.8%
Top 10 Hldgs %
40.45%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$13M
2
CMG icon
Chipotle Mexican Grill
CMG
+$8.2M
3
CELG
Celgene Corp
CELG
+$6.34M
4
CMRX
Chimerix, Inc.
CMRX
+$5.55M
5
DYAX
DYAX CORPORATION
DYAX
+$5.42M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 43.09%
2 Consumer Discretionary 6.1%
3 Materials 3.81%
4 Consumer Staples 3.68%
5 Technology 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
76
Arrowhead Research
ARWR
$10.1B
$319K 0.24%
+51,847
New +$294K
RCKT icon
77
Rocket Pharmaceuticals
RCKT
$372M
$299K 0.22%
+6,605
New +$288K
BIIB icon
78
PUT
Biogen
BIIB
$30.8B
$297K 0.22%
+11,500
New +$3.3M
GWPH
79
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$293K 0.22%
+38,800
New +$3.16M
ALDR
80
DELISTED
Alder Biopharmaceuticals
ALDR
$288K 0.21%
+8,716
New +$295K
FMI
81
DELISTED
Foundation Medicine, Inc.
FMI
$282K 0.21%
+13,387
New +$258K
OPK icon
82
Opko Health
OPK
$899M
$274K 0.2%
+27,266
New +$273K
PCRX icon
83
Pacira BioSciences
PCRX
$1.01B
$269K 0.2%
+3,500
New +$198K
ANAC
84
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$269K 0.2%
+10,000
New +$1.1M
VZ icon
85
Verizon
VZ
$183B
$264K 0.19%
+5,709
New +$259K
LLY icon
86
Eli Lilly
LLY
$1.04T
$263K 0.19%
+3,119
New +$259K
P
87
PUT
DELISTED
Pandora Media Inc
P
$260K 0.19%
+16,000
New +$238K
EMC
88
DELISTED
EMC CORPORATION
EMC
$257K 0.19%
+10,000
New +$260K
BABA icon
89
PUT
Alibaba
BABA
$282B
$254K 0.19%
+11,100
New +$871K
GMCR
90
PUT
DELISTED
KEURIG GREEN MTN INC
GMCR
$254K 0.19%
+8,000
New +$497K
IBRX icon
91
ImmunityBio
IBRX
$7.8B
$251K 0.19%
+14,471
New +$215K
EA icon
92
Electronic Arts
EA
$52.1B
$250K 0.18%
+3,642
New +$256K
SCYX icon
93
SCYNEXIS
SCYX
$44.5M
$235K 0.17%
+473
New +$249K
NSM
94
PUT
DELISTED
Nationstar Mortgage Holdings
NSM
$234K 0.17%
+9,200
New +$122K
DSCI
95
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$232K 0.17%
+50,817
New +$241K
HUM icon
96
PUT
Humana
HUM
$46.4B
$228K 0.17%
+9,400
New +$1.65M
ESPR
97
DELISTED
Esperion Therapeutics
ESPR
$223K 0.16%
+10,000
New +$252K
RPTP
98
PUT
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$220K 0.16%
+127,400
New +$739K
P
99
DELISTED
Pandora Media Inc
P
$215K 0.16%
+16,000
New +$238K
MAT icon
100
CALL
Mattel
MAT
$4.26B
$213K 0.16%
+50,000
New +$1.23M
2 3
4
5 6

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for FT Options, which disclosed 204 positions worth $136M. Its ten largest holdings account for 40% of the portfolio.

Its largest position is Gilead Sciences: 125,233 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Materials.

  • FT Options's largest Q4 2015 buy was Gilead Sciences: 125,233 shares worth $12.7M.
  • FT Options's ten largest holdings make up 40% of its $136M portfolio in Q4 2015.
  • FT Options disclosed 204 positions in Q4 2015, its first 13F filing on record.

Based on FT Options's 13F filing for Q4 2015, filed 5 Feb 2016.